• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病中的炎症和先天免疫反应受损。

An Impaired Inflammatory and Innate Immune Response in COVID-19.

机构信息

Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.

出版信息

Mol Cells. 2021 Jun 30;44(6):384-391. doi: 10.14348/molcells.2021.0068.

DOI:10.14348/molcells.2021.0068
PMID:34098591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8245320/
Abstract

The recent appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people around the world and caused a global pandemic of coronavirus disease 2019 (COVID-19). It has been suggested that uncontrolled, exaggerated inflammation contributes to the adverse outcomes of COVID-19. In this review, we summarize our current understanding of the innate immune response elicited by SARS-CoV-2 infection and the hyperinflammation that contributes to disease severity and death. We also discuss the immunological determinants behind COVID-19 severity and propose a rationale for the underlying mechanisms.

摘要

最近出现的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)已经影响了全球数百万人,并导致了 2019 年冠状病毒病(COVID-19)的全球大流行。有人认为,不受控制的、过度的炎症反应是导致 COVID-19 不良后果的原因。在这篇综述中,我们总结了我们目前对 SARS-CoV-2 感染引起的先天免疫反应以及导致疾病严重程度和死亡的过度炎症的理解。我们还讨论了 COVID-19 严重程度背后的免疫学决定因素,并提出了潜在机制的基本原理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/8245320/d82775f75db9/molce-44-6-384-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/8245320/fc8ccb4846c2/molce-44-6-384-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/8245320/d82775f75db9/molce-44-6-384-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/8245320/fc8ccb4846c2/molce-44-6-384-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/8245320/d82775f75db9/molce-44-6-384-f2.jpg

相似文献

1
An Impaired Inflammatory and Innate Immune Response in COVID-19.新型冠状病毒病中的炎症和先天免疫反应受损。
Mol Cells. 2021 Jun 30;44(6):384-391. doi: 10.14348/molcells.2021.0068.
2
SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.SARS-CoV-2 与人类宿主的多方面相互作用。第一部分:迄今为止我们所了解和所做的,以及仍然未知的现实。
IUBMB Life. 2020 Nov;72(11):2313-2330. doi: 10.1002/iub.2380. Epub 2020 Sep 12.
3
Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.个体间免疫原性变异:对冠状病毒、呼吸道合胞病毒和流感病毒的易感性。
Rev Med Virol. 2021 Nov;31(6):e2234. doi: 10.1002/rmv.2234. Epub 2021 Mar 16.
4
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.
5
SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.SARS-CoV-2 与人类宿主的多方面相互作用。第二部分:先天免疫反应、免疫病理学和表观遗传学。
IUBMB Life. 2020 Nov;72(11):2331-2354. doi: 10.1002/iub.2379. Epub 2020 Sep 16.
6
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.有前景的药物再利用方法针对与 SARS-CoV-2 并发症相关的细胞因子风暴。
Immunopharmacol Immunotoxicol. 2021 Aug;43(4):395-409. doi: 10.1080/08923973.2021.1931302. Epub 2021 May 31.
7
The role and delicate balance of Host Immunity in Coronavirus Disease-19.宿主免疫在新型冠状病毒疾病中的作用和微妙平衡。
Iran J Immunol. 2021 Mar;18(1):1-12. doi: 10.22034/iji.2021.88526.1874.
8
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.新型冠状病毒刺突糖蛋白 S1 重组蛋白诱导人外周血单个核细胞过度细胞因子产生及其地塞米松抑制作用。
Inflammation. 2021 Oct;44(5):1865-1877. doi: 10.1007/s10753-021-01464-5. Epub 2021 Apr 16.
9
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.中性粒细胞胞外陷阱 (NETs) 与新冠病毒 2019 (Covid-19):治疗模式的新前沿。
Int Immunopharmacol. 2022 Mar;104:108516. doi: 10.1016/j.intimp.2021.108516. Epub 2022 Jan 6.
10
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.Janus 激酶 1/2 抑制剂芦可替尼治疗伴有严重全身炎症反应的 COVID-19。
Leukemia. 2020 Jul;34(7):1805-1815. doi: 10.1038/s41375-020-0891-0. Epub 2020 Jun 9.

引用本文的文献

1
Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies.新型冠状病毒 2 型的神经精神负担:对其病理生理学、潜在机制及管理策略的综述
Viruses. 2024 Nov 21;16(12):1811. doi: 10.3390/v16121811.
2
Meeting the Challenge of Controlling Viral Immunopathology.应对控制病毒免疫病理学的挑战。
Int J Mol Sci. 2024 Apr 1;25(7):3935. doi: 10.3390/ijms25073935.
3
A comprehensive investigation on the receptor BSG expression reveals the potential risk of healthy individuals and cancer patients to 2019-nCoV infection.

本文引用的文献

1
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.大规模单细胞转录组图谱揭示的 COVID-19 免疫特征。
Cell. 2021 Apr 1;184(7):1895-1913.e19. doi: 10.1016/j.cell.2021.01.053. Epub 2021 Feb 3.
2
Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation.I 型干扰素在 SARS-CoV-2 诱导的炎症中的双重性质。
Trends Immunol. 2021 Apr;42(4):312-322. doi: 10.1016/j.it.2021.02.003. Epub 2021 Feb 12.
3
Multi-organ proteomic landscape of COVID-19 autopsies.COVID-19 尸检的多器官蛋白质组学图谱。
对受体 BSG 表达的全面研究揭示了健康个体和癌症患者感染 2019-nCoV 的潜在风险。
Aging (Albany NY). 2024 Mar 13;16(6):5412-5434. doi: 10.18632/aging.205655.
4
Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey.SARS-CoV-2原型株或其变体在恒河猴中诱导的不同早期免疫反应的单细胞转录组图谱
MedComm (2020). 2023 Nov 20;4(6):e432. doi: 10.1002/mco2.432. eCollection 2023 Dec.
5
Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 Network Pharmacology, Computational Biology, and Surface Plasmon Resonance Verification.探讨牛膝木瓜方治疗 2019 年冠状病毒病的分子机制:网络药理学、计算生物学和表面等离子体共振验证。
Curr Comput Aided Drug Des. 2024;20(7):1113-1129. doi: 10.2174/0115734099272592231004170422.
6
Comprehensive molecular expression profiling of SARS-CoV-associated factors in the endometrium across the menstrual cycle and elevated susceptibility in women with recurrent pregnancy loss.月经周期中子宫内膜SARS-CoV相关因子的综合分子表达谱分析以及复发性流产女性的易感性增加。
Front Genet. 2023 Oct 3;14:1246725. doi: 10.3389/fgene.2023.1246725. eCollection 2023.
7
Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019.轻度 COVID-19 后腺苷脱氨酶活性和血管内皮功能障碍的变化。
Int J Mol Sci. 2023 Aug 24;24(17):13140. doi: 10.3390/ijms241713140.
8
COVID-19 Spotlights Connections between Disease and Multiple Lifestyle Factors.新冠疫情凸显了疾病与多种生活方式因素之间的关联。
Am J Lifestyle Med. 2022 Sep 5;17(2):231-257. doi: 10.1177/15598276221123005. eCollection 2023 Mar-Apr.
9
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial.美泊利单抗治疗住院的重症 COVID-19 成年患者(DEFLECT):一项多中心、无缝隙 2/3 期、随机、第三方双盲临床试验。
Signal Transduct Target Ther. 2023 Jan 30;8(1):46. doi: 10.1038/s41392-023-01323-9.
10
Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases.分析轻、重症 COVID-19 患者鼻咽环境中促炎细胞因子的差异基因表达。
PLoS One. 2022 Dec 30;17(12):e0279270. doi: 10.1371/journal.pone.0279270. eCollection 2022.
Cell. 2021 Feb 4;184(3):775-791.e14. doi: 10.1016/j.cell.2021.01.004. Epub 2021 Jan 9.
4
Global absence and targeting of protective immune states in severe COVID-19.严重 COVID-19 中保护性免疫状态的全球缺失和靶向治疗。
Nature. 2021 Mar;591(7848):124-130. doi: 10.1038/s41586-021-03234-7. Epub 2021 Jan 25.
5
Immune determinants of COVID-19 disease presentation and severity.COVID-19 疾病表现和严重程度的免疫决定因素。
Nat Med. 2021 Jan;27(1):28-33. doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.
6
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.新型冠状病毒肺炎中受感染的巨噬细胞和 T 细胞之间的回路。
Nature. 2021 Feb;590(7847):635-641. doi: 10.1038/s41586-020-03148-w. Epub 2021 Jan 11.
7
Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity.外周血细胞中的染色质重塑反映了新冠病毒疾病(COVID-19)的症状严重程度。
bioRxiv. 2020 Dec 9:2020.12.04.412155. doi: 10.1101/2020.12.04.412155.
8
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.纵向多组学分析鉴定出巨核细胞、红细胞和浆细胞反应为严重 COVID-19 的特征。
Immunity. 2020 Dec 15;53(6):1296-1314.e9. doi: 10.1016/j.immuni.2020.11.017. Epub 2020 Nov 26.
9
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.TNF-α 和 IFN-γ 的协同作用可引发 SARS-CoV-2 感染和细胞因子休克综合征中的炎症细胞死亡、组织损伤和死亡。
Cell. 2021 Jan 7;184(1):149-168.e17. doi: 10.1016/j.cell.2020.11.025. Epub 2020 Nov 19.
10
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.通过I/III型干扰素的时间模式及流感对比揭示的新冠病毒感染中失调的抗病毒免疫
Nat Immunol. 2021 Jan;22(1):32-40. doi: 10.1038/s41590-020-00840-x. Epub 2020 Dec 4.